Synthesis, Molecular Properties Prediction, and Anti-staphylococcal Activity of N-Acylhydrazones and New 1,3,4-Oxadiazole Derivatives

Cohen, 1997, Microbial resistance to drug therapy: A review, Am. J. Infect. Control, 25, 51, 10.1016/S0196-6553(97)90054-7

Simoens, 2010, Health economics of antibiotics, Pharmaceuticals, 3, 1348, 10.3390/ph3051348

McBride, 2010, Chemoprophylaxis of tropical infectious diseases, Pharmaceuticals, 3, 1561, 10.3390/ph3051561

Smith, 2005, Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus, Phytother. Res., 19, 538, 10.1002/ptr.1711

Gibbons, 2004, Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus, Plant Lett., 70, 1

Ortega, 2010, Multiple roles of Staphylococcus aureus enterotoxins: Pathogenicity, superantigenic activity, and correlation to antibiotic resistance, Toxins, 2, 2117, 10.3390/toxins2082117

Masunari, 2007, 3D QSAR studies of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus, Braz. J. Pharm. Sci., 43, 281

Saadeh, 2009, Synthesis of novel hybrid molecules from precursors with known antiparasitic activity, Molecules, 14, 1483, 10.3390/molecules14041483

Salomon, 2012, First century of Chagas’ disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems, J. Pharm. Sci., 101, 888, 10.1002/jps.23010

Ancizu, 2009, Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs, Molecules, 14, 2256, 10.3390/molecules14062256

Oliveira, 2011, Drug resistance modulation in Staphylococcus aureus, a new biological activity for mesoionic hydrochloride compounds, Molecules, 16, 2023, 10.3390/molecules16032023

Kadi, 2007, Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles, Eur. J. Med. Chem., 42, 235, 10.1016/j.ejmech.2006.10.003

Chandrakantha, 2010, Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-fluoro-4-methoxy phenyl moiety, Eur. J. Med. Chem., 45, 1206, 10.1016/j.ejmech.2009.11.046

Kumar, 2010, Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents, Eur. J. Med. Chem., 45, 2063, 10.1016/j.ejmech.2010.01.045

Karaali, 2010, Synthesis and antimicrobial activities of some new 1,2,4-triazole derivatives, Molecules, 15, 2427, 10.3390/molecules15042427

Fuloria, 2009, Synthesis and antimicrobial evaluation of some new oxadiazoles derived from phenylpropionohydrazides, Molecules, 14, 1898, 10.3390/molecules14051898

Weng, 2012, Synthesis, structure and antifungal activity of new 3-[(5-aryl-1,3,4-oxadiazol-2-yl)methyl]benzo[d]thiazol-2(3H)-ones, Molecules, 17, 989, 10.3390/molecules17010989

Manjunatha, 2010, Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives, Eur. J. Med. Chem., 45, 5225, 10.1016/j.ejmech.2010.08.039

Husain, 2009, Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl)]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents, Eur. J. Med. Chem., 44, 3798, 10.1016/j.ejmech.2009.04.009

Iqbal, 2006, Synthesis, antimicrobial and anti-HIV activity of some novel benzenesulfonamides bearing 2,5-disubstituted-1,3,4-oxadiazole moiety, J. Chin. Chem. Soc., 53, 689, 10.1002/jccs.200600091

Johns, 2009, 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position, Bioorg. Med. Chem. Lett., 19, 1807, 10.1016/j.bmcl.2009.01.089

Savariz, 2010, Synthesis, antitumor and antimicrobial activity of novel 1-substituted phenyl-3-[3-alkylamino(methyl)-2-thioxo-1,3,4-oxadiazol-5-yl]-b-carboline derivatives, J. Braz. Chem. Soc., 21, 288, 10.1590/S0103-50532010000200014

Lee, 2010, Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4, J. Med. Chem., 53, 325, 10.1021/jm901268n

Bankar, 2009, Vasorelaxant effect in rat aortic rings through calcium channel blockage: A preliminary in vitro assessment of a 1,3,4-oxadiazole derivative, Chem. Biol. Interact., 181, 377, 10.1016/j.cbi.2009.07.014

Ducharme, 2010, The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor, Med. Chem. Lett., 1, 170, 10.1021/ml100029k

Gosselin, 2010, A practical synthesis of 5-lipoxygenase inhibitor MK-0633, J. Org. Chem., 75, 4154, 10.1021/jo100561u

Zarghi, 2005, Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles, Bioorg. Chem. Lett., 15, 1863, 10.1016/j.bmcl.2005.02.014

Rajak, 2010, Novel semicarbazones based 2,5-disubstituted-1,3,4-oxadiazoles: One more step towards establishing four binding site pharmacophoric model hypothesis for anticonvulsant activity, Bioorg. Med. Chem. Lett., 20, 4168, 10.1016/j.bmcl.2010.05.059

Savarino, 2006, A historical sketch of the discovery and development of HIV-1 integrase inhibitors, Expert Opin. Inv. Drug., 15, 1507, 10.1517/13543784.15.12.1507

Schlecker, 1988, The synthesis of antihypertensive 3-(1,3,4-oxadiazol-2-yl)phenoxypropanolahines, Tetrahedron, 44, 3289, 10.1016/S0040-4020(01)85962-7

Ogata, 1971, In vitro sensitivity of mycoplasmas isolated from various animals and sewage of antibiotics and nitrofurans, J. Antibiot., 24, 443, 10.7164/antibiotics.24.443

Vardan, 1983, Effects of tiodazosin, a new antihypertensive, hemodynamics and clinical variables, Clin. Pharm. Ther., 34, 290, 10.1038/clpt.1983.170

Rando, 2008, Antileishmanial activity screening of 5-nitro-2-hetetocyclic benzylidene hydrazides, Bioorg. Med. Chem., 16, 6724, 10.1016/j.bmc.2008.05.076

Cerioni, 2009, Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. investigation on a case of very remote hammett correlation, Magn. Reson. Chem., 47, 727, 10.1002/mrc.2453

Fuloria, 2009, Synthesis and antimicrobial evaluation of some new oxadiazoles derived from phenylpropionohydrazides, Molecules, 14, 1898, 10.3390/molecules14051898

Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1

(2012, February 10). Cheminformatics on the web. Available online: http://www.molinspiration.com/.

(2012, February 10). Organic Chemistry Portal. Available online: http://www.organic-chemistry.org/prog/peo/.

Zhao, 2002, Rate-limited steps of human oral absorption and QSAR studies, Pharm. Res., 19, 1446, 10.1023/A:1020444330011

Gibbons, 2004, Anti-staphylococcal plant natural products, Nat. Prod. Rep., 21, 263, 10.1039/b212695h

Hafidh, 2011, Inhibition of growth of highly resistant bacterial and fungal pathogens by a natural product, Open Microbiol. J., 5, 96, 10.2174/1874285801105010096

Kaatz, 1995, Inducible NorA-mediated multidrug resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 39, 2650, 10.1128/AAC.39.12.2650

Ross, 1989, Characterisation and molecular cloning of the novel macrolide streptogramin B resistance determinant from Staphylococcus epidermidis, J. Antimicrob. Chemother., 24, 851, 10.1093/jac/24.6.851

Gibbons, 2000, The effect of reserpine, a modulator of multidrug efflux, on the in vitro activity of tetracycline against clinical isolates of methicillin resistance Staphylococcus aureus (MRSA) possessing the tet (K) determinant, Phytother. Res., 14, 139, 10.1002/(SICI)1099-1573(200003)14:2<139::AID-PTR608>3.0.CO;2-8